Featured Research

from universities, journals, and other organizations

Results of dengue vaccine trial in over 4000 Thai children: Experts respond

Date:
September 11, 2012
Source:
Australian Science Media Centre (AusSMC)
Summary:
Researchers from France and Thailand have trialled a dengue vaccine in over 4000 Thai children. While overall there was no difference between the number of dengue cases recorded following vaccination, secondary tests showed that the vaccine was effective against three of the four dengue viruses.

Researchers from France and Thailand have trialled a dengue vaccine in over 4000 Thai children. While overall there was no difference between the number of dengue cases recorded following vaccination, secondary tests showed that the vaccine was effective against three of the four dengue viruses.

Dengue is not caused by a single virus, but rather by four different related viruses (known as DENV 1, 2, 3 and 4), making development of an effective vaccine considerably more complicated than for some viral diseases. Dengue is one of the most widespread mosquito-borne viral diseases in the world, with WHO estimating that around half of the world's population are currently at risk. There is currently no vaccine to protect against dengue.

Below are responses to the study, details of which can be downloaded using the link below from experts around the world.

Professor Scott O'Neill is Dean of Science and Chief Investigator on the Eliminate Dengue Program at Monash University.

"The question is, is the glass half-empty or half-full? True the vaccine shows protection against three of the strains, but unfortunately -- and this is very disappointing -- overall it was not effective, showing no protection for the most common dengue strains circulating in Thailand. This is a very disappointing result for people interested in dengue that have been following this research -- we were all hoping for a much stronger result. The current data suggest that there is still more work needed on dengue vaccine development.

Our team is working on an alternative approach which could be used in unison with a vaccine to help make it more effective. We've developed a way to stop mosquitoes from transmitting the virus. We infect the mosquitoes with a naturally occurring bacterium called Wolbachia and this reduces their ability to become infected with dengue. We're currently testing our technique in real-life situations in Queensland, Vietnam, Indonesia and Brazil."

Professor Cameron Simmons is a Wellcome Trust Senior Research Fellow at the Centre for Tropical Medicine, Oxford University Clinical Research Unit in Vietnam

"Dengue is a mosquito-carried viral disease that afflicts ~100 million people, mainly children, every year. Dengue is a constant disease threat to Australian travellers visiting SE Asia and Latin America, and in turn, to residents of Far North Queensland when returned travellers with dengue generate local epidemics in their communities. Those unlucky enough to have had dengue will attest to the moniker 'break-bone fever' being an accurate description of this miserable illness. Thus, the announcement of results from the first large-scale field trial of a dengue vaccine in ~4000 Thai children by the drug company Sanofi Pasteur is a wonderful step forward in the fight against this public health menace.

The study results indicated the vaccine was safe but somewhat disappointingly provided protection against only 3 of the 4 dengue viruses that infect humans. Further large-scale testing of this vaccine is ongoing with the hope of creating pivotal evidence of protection against all four of the dengue viruses. For dengue, the 'holy grail' has always been to create a cheap, safe, simple to use and effective vaccine. The results obtained in this current trial suggest the holy grail, while still elusive, is one small step closer."

Professor Suresh Mahalingam is an ARC Future Fellow and Principal Research Leader of the Emerging Viruses and Inflammation Research Group at Griffith University

"Antibody-dependent enhancement (ADE) is the phenomenon in which non-neutralising antiviral antibodies cause enhanced viral infection of host cells. There are a number of epidemiological studies that show that dengue haemorrhagic fever occurs in patients who have undergone a secondary dengue infection. This is one of the major challenges in the development of an effective dengue vaccine. However, ADE has largely been described in vitro and it has been difficult to demonstrate its clinical relevance to dengue infection. Nevertheless ADE poses difficulties for efforts to develop dengue vaccines. A suitable vaccine against dengue should provide long term immunity with antibody responses effective against all the four DV serotypes, without development of sub-neutralizing antibodies that may induce ADE.

This recent study is a major breakthrough as their candidate vaccine was immunogenic for all four serotypes and protected against three of the four serotypes (1, 3, and 4). Importantly, there was no sign of enhanced disease with this vaccine showing great promise."


Story Source:

The above story is based on materials provided by Australian Science Media Centre (AusSMC). Note: Materials may be edited for content and length.


Journal Reference:

  1. Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul, Kriengsak Limkittikul, Pornthep Chanthavanich, Saravudh Suvannadabba, Vithaya Jiwariyavej, Wut Dulyachai, Krisana Pengsaa, T Anh Wartel, Annick Moureau, Melanie Saville, Alain Bouckenooghe, Simonetta Viviani, Nadia G Tornieporth, Jean Lang. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet, 2012; DOI: 10.1016/S0140-6736(12)61428-7

Cite This Page:

Australian Science Media Centre (AusSMC). "Results of dengue vaccine trial in over 4000 Thai children: Experts respond." ScienceDaily. ScienceDaily, 11 September 2012. <www.sciencedaily.com/releases/2012/09/120911090554.htm>.
Australian Science Media Centre (AusSMC). (2012, September 11). Results of dengue vaccine trial in over 4000 Thai children: Experts respond. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2012/09/120911090554.htm
Australian Science Media Centre (AusSMC). "Results of dengue vaccine trial in over 4000 Thai children: Experts respond." ScienceDaily. www.sciencedaily.com/releases/2012/09/120911090554.htm (accessed July 29, 2014).

Share This




More Plants & Animals News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com
Asteroid's Timing Was 'Colossal Bad Luck' For The Dinosaurs

Asteroid's Timing Was 'Colossal Bad Luck' For The Dinosaurs

Newsy (July 28, 2014) The asteroid that killed the dinosaurs struck at the worst time for them. A new study says that if it hit earlier or later, they might've survived. Video provided by Newsy
Powered by NewsLook.com
Raw: Sea Turtle Hatchlings Emerge from Nest

Raw: Sea Turtle Hatchlings Emerge from Nest

AP (July 27, 2014) A live-streaming webcam catches loggerhead sea turtle hatchlings emerging from a nest in the Florida Keys. (July 27) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins